Anti-EGFR antibody drug conjugates
The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs. Formula (IIa), (IIb), (IIc)
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
03.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs. Formula (IIa), (IIb), (IIc) |
---|---|
Bibliography: | Application Number: AU20170277517 |